Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Chill Yee MD
Chill C. Yee MD Advisory Board
David Rakel MD, FAAFP
David Rakel MD, FAAFP Editor-in-Chief
Irene Hamrick MD, FAAFP, AGSF, CMD
Irene Hamrick MD, FAAFP, AGSF, CMD Advisory Board
See All Experts
story of the week
Published in Primary Care and
1 other channel

Journal Scan / Research · February 27, 2020

Cardiovascular and Safety Outcomes of Chlorthalidone vs Hydrochlorothiazide in Hypertension

JAMA Internal Medicine

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Peter Lin MD, CCFP

JAMA Internal Medicine
Comparison of Cardiovascular and Safety Outcomes of Chlorthalidone vs Hydrochlorothiazide to Treat Hypertension
JAMA Intern Med 2020 Feb 17;[EPub Ahead of Print], G Hripcsak, MA Suchard, S Shea, R Chen, SC You, N Pratt, D Madigan, HM Krumholz, PB Ryan, MJ Schuemie

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Recently Updated